The clinical outcomes of adjuvant gemcitabine plus S-1 in resected pancreatic cancer: a single-center retrospective study

The clinical outcomes of adjuvant gemcitabine plus S-1 in resected pancreatic cancer: a single-center retrospective study

Abstract Background Adjuvant chemotherapy is the standard form of care for resected pancreatic cancer (PC) patients. Its treatment regimens include monotherapy with gemcitabine or S-1 and combination therapy with gemcitabine plus capecitabine or modified FOLFIRINOX (fluorouracil, oxaliplatin, irinot...

Full description

Saved in:
Bibliographic Details
Main Authors: Kuan-Yu Tseng, Yi-Ju Chen, Chiann-Yi Hsu, Yu-Hsuan Shih, Hsin-Chen Lin
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Cancer
Subjects:
Adjuvant chemotherapy
Pancreatic cancer
Gemcitabine plus S-1
Disease-free survival
Overall survival
Online Access:https://doi.org/10.1186/s12885-025-14617-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14617-8

Similar Items